CT-109

N/A

Report date: 2022/07/01 15:29:28

Base Information

Drug NameCT-109
Drug Alias NameCT-109
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionAnti-CEACAM6
TargetsCarcinoembryonic antigen related cell adhesion molecule 6
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesStromatis Bioscience
China Registration ClassN/A

Develop Information

Active CompaniesStromatis Bioscience
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A